Annual Report 2012
Annual Report 2012
Annual Report 2012
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Plant and Equipment<br />
1. Overview of Capital Investments, etc.<br />
The Group (the Company and its consolidated subsidiaries) has<br />
focused on investing in research and development and product<br />
areas where growth can be expected in the future for energy<br />
efficiency, rationalization, product quality improvement, and increasing<br />
production capacity. Capital investment (tangible fixed assets on an<br />
acceptance basis; figures shown do not include consumption tax,<br />
etc.) during this consolidated fiscal year totaled ¥33.5 billion (US$408.1<br />
million). Capital investment by business segment is shown below.<br />
The medical business segment made capital investments mainly<br />
to increase production capacity and for production rationalization at<br />
the Company’s Odate Plant and Nipro (Thailand) Corporation Ltd. In<br />
addition, Nipro India Corporation Pvt. Ltd. and Nipro Medical (Hefei)<br />
Co., Ltd. undertook the construction of new plants.<br />
In the pharmaceutical business segment Nipro Pharma Corporation<br />
made capital investments mainly in facilities to manufacture<br />
anticancer drug preparations at the Odate Plant and for infusion<br />
solution preparations at the Ise Plant. Tohoku Nipro Pharmaceutical<br />
Corporation made capital investments for the purpose of recovery<br />
following the Great East Japan Earthquake.<br />
2. Status of Major Plant and Equipment<br />
(1) <strong>Report</strong>ing Companies<br />
As of March 31, <strong>2012</strong><br />
Name of Facility<br />
(Location)<br />
15 Nipro Corporation <strong>Annual</strong> <strong>Report</strong> <strong>2012</strong><br />
Name of Segment by<br />
Business Category<br />
Type of Asset<br />
The materials business segment made capital investments mainly<br />
for the production of glass tubes and bottles at the Company’s Otsu<br />
Plant.<br />
Corporate capital investments were made primarily in equipment<br />
and devices for research and development at the Company’s<br />
Research and Development Laboratory and Pharmaceutical Research<br />
Center.<br />
The required funds were allocated mainly from owned capital and<br />
loans.<br />
There was no material retirement or disposal of plants and equipment.<br />
Millions of yen<br />
Thousands of<br />
U.S. dollars<br />
Medical ········································· ¥ 18,689 $ 227,388<br />
Pharmaceutical ····························· 13,501 164,266<br />
Materials ······································· 935 11,376<br />
Corporate ····································· 416 5,061<br />
Total ············································· ¥ 33,542 $ 408,091<br />
Book Value (Millions of yen) Number of Employees<br />
(People)<br />
Buildings and Structures Machinery and Equipment Land (Area m 2 ) Construction in Progress Total<br />
Odate Plant Medical Medical Equipment ¥ 8,638 ¥ 10,164 ¥ 961 ¥ 358 ¥ 20,121 1,217<br />
(Odate, Akita) Production Facilities, etc. (198,026)<br />
Otsu Plant Materials Glass Tube Processing 160 111 25 52 348 36<br />
(Otsu, Shiga) Production Facilities, etc. (4,604)<br />
Tokyo Office Materials Sales Facilities 245 37 2,092 — 2,374 20<br />
(Bunkyo-ku, Tokyo) (441)<br />
Domestic Operations Medical Sales Facilities 379 550 357 11 1,297 675<br />
21 Branches and (2,566)<br />
33 Sales Offices in Japan<br />
Research and Development Corporate Research and Development 1,874 544 467 — 2,885 250<br />
Laboratory & Pharmaceutical Plant and Equipment, etc. (26,544)<br />
Research Center (Kusatsu, Shiga)<br />
Headquarters Medical Other Plant and Equipment 323 377 1,508 2 2,210 169<br />
(Kita-ku, Osaka) Materials (1,891)<br />
Corporate<br />
Leased Assets and Others Other Other Plant and Equipment 1,063 1 4,760 — 5,824 —<br />
(Settsu, Osaka, Other) (53,650)<br />
[21,020] *Note:(1)<br />
Name of Facility<br />
(Location)<br />
Name of Segment by<br />
Business Category<br />
Type of Asset<br />
Book Value (Thousands of U.S. dollars) Number of Employees<br />
(People)<br />
Buildings and Structures Machinery and Equipment Land (Area m 2 ) Construction in Progress Total<br />
Odate Plant Medical Medical Equipment $ 105,098 $ 123,665 $ 11,692 $ 4,356 $ 244,811 1,217<br />
(Odate, Akita) Production Facilities, etc. (198,026)<br />
Otsu Plant Materials Glass Tube Processing 1,947 1,350 304 633 4,234 36<br />
(Otsu, Shiga) Production Facilities, etc. (4,604)<br />
Tokyo Office Materials Sales Facilities 2,981 450 25,453 — 28,884 20<br />
(Bunkyo-ku, Tokyo) (441)<br />
Domestic Operations Medical Sales Facilities 4,611 6,692 4,344 134 15,781 675<br />
21 Branches and (2,566)<br />
33 Sales Offices in Japan<br />
Research and Development Corporate Research and Development 22,801 6,619 5,682 — 35,102 250<br />
Laboratory & Pharmaceutical Plant and Equipment, etc. (26,544)<br />
Research Center (Kusatsu, Shiga)<br />
Headquarters Medical Other Plant and Equipment 3,930 4,587 18,348 24 26,889 169<br />
(Kita-ku, Osaka) Materials (1,891)<br />
Corporate<br />
Leased Assets and Others Other Other Plant and Equipment 12,933 12 57,915 — 70,860 —<br />
(Settsu, Osaka, Other) (53,650)<br />
[21,020] *Note:(1)
Change language